EarningsORIONPHARM
ORIONPHARM Earnings Update
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 15 November 2022. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Q1 Un-audited): Consolidated EPS was Tk. 0.72 for July-September 2022 as against Tk. 0.30 for July-September 2021; Consolidated NOCFPS was Tk. 2.25 for July-September 2022 as against Tk. 1.52 for July-September 2021. Consolidated NAV per share (including revaluation surplus) was Tk. 92.65 as on September 30, 2022 and Tk. 82.53 as on June 30, 2022. Consolidated NAV per share (excluding revaluation surplus) was Tk. 84.75 as on September 30, 2022 and Tk. 74.62 as on June 30, 2022. (cont.)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 63730efdb2c2584194901fd7
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.